PhaseV is a technology company leveraging advanced causal inference and machine learning to innovate clinical trials. Our technology and methods enable to optimize trial design by detecting hidden signals in existing clinical data and extracting actionable insights, as well as supporting advanced adaptive designs for more efficient, precise and successful clinical trials. For more information, go to www.phasevtrials.com

WCG is a global leader of solutions that measurably improve and accelerate clinical research. Biopharmaceutical and medical device companies, contract research organizations (CROs), research institutions, and sites partner with us for our unmatched expertise, data intelligence, and purpose-built technology to make informed decisions and optimize study outcomes, while maintaining the highest standards of human participant protection. WCG raises the bar by pioneering new concepts, reimagining processes, fostering compliance and safety, and empowering those who perform clinical trials to accelerate the delivery of medical therapies and devices that improve lives. For more information, please visit wcgclinical.com.

Entos Pharmaceuticals Inc. is a clinical-stage genetic medicines company headquartered in Canada, with offices in the USA and UK. Entos leverages its proprietary Fusogenix™ platform in its own drug development programs and multiple licenses with pharmaceutical companies. Most recently, Entos partnered with Lilly to develop CNS and PNS-targeted genetic therapies. Learn more at www.entospharma.com

A global provider of healthcare manufacturing solutions, MGS provides the right balance to drive vital innovations: robust, vertically integrated global capabilities combined with the strong customer focus and seamless collaboration of an agile partner. That’s why we’re the global healthcare manufacturing partner of choice for today’s leading Pharma, Diagnostic and MedTech companies. For more Information, please visit https://www.mgsmfg.com/

Mana.bio aims to unlock RNA therapy by developing a novel AI-based RNA delivery platform. By utilizing high throughput screening and AI, Mana created a highly efficient, ex-liver cell-specific non-viral RNA delivery solution. Mana built predictive AI models and achieved novel IP-protected in vivo results, including lung-specific delivery of mRNA.

Quotient Sciences is a drug development and manufacturing accelerator providing integrated programs and tailored services across the entire development pathway. Cutting through silos across a range of drug development capabilities, we save precious time and money in getting drugs to patients. Everything we do for our customers is driven by an unswerving belief that ideas need to become solutions, molecules need to become cures, fast. Because humanity needs solutions, fast. For more information, please visit https://www.quotientsciences.com/

Gerresheimer is an innovative systems and solutions provider and a global partner for the pharma, biotech and cosmetic industries. The company offers a comprehensive portfolio of pharmaceutical primary packaging, drug delivery systems and digital solutions. Gerresheimer ensures that medicines reach patients safely and can be administered reliably. With around 12,000 employees and 35 production sites in 16 countries in Europe, America and Asia, Gerresheimer has a global presence and produces locally for the regional markets with a focus on the pharma industry. For more information, visit www.gerresheimer.com

OncoHost is a technology company transforming the approach to precision medicine for improved patient outcomes. Its proprietary platform, PROphet®, is a plasma-based, proteomic pattern analysis tool whose initial offering in non-small cell lung cancer (NSCLC) uses a single blood sample to guide first-line immunotherapy decision-making. The PROphetNSCLC™ test provides clear clinical utility by offering physicians crucial guidance on the optimal first-line immunotherapy treatment plan for each individual patient, with a significant effect on overall survival. Led by an experienced team of entrepreneurs and industry experts and supported by a large-scale prospective clinical trial with over 40 sites and 1,700 patients recruited worldwide, OncoHost is well-positioned to lead precision diagnostics and biomarker development to the next stage. For more information, go to https://www.oncohost.com/

The Epitomee Oral Delivery of Biologics Platform enables the delivery of large amounts of hard-to-deliver biologics with enhanced bioavailability. Our innovative drug delivery system is designed to transport drugs to the small intestine and through the GI wall, achieving effective bioavailability. For more information, please visit https://epitomeemedical.com/

Pyramid Labs provides contract development, manufacturing and analytical services for parenteral drugs. From pre-clinical development to commercial supply and regulatory support, our expertise has enabled multiple clients to develop and launch their biologics, peptide and small molecule drugs. For more information, go to https://www.pyramidlabs.com/

Vivani Medical is an emerging biopharmaceutical company aiming to make chronic disease treatments easier, more convenient, and potentially more tolerable, by developing miniature, ultra long-acting subdermal implants designed to address medication non-adherence. Vivani’s initial focus is on GLP-1 treatment for obesity and type 2 diabetes. Learn more at vivani.com.

The Medical Affairs Consulting Team at Lumanity was developed to empower your organization to deliver impact. Our medical affairs programs are designed to help your team identify, analyze, and utilize actionable information. We can help you recognize the most critical insights from your in-house and field teams, and then capitalize on that knowledge to build your medical affairs plans, strengthen your engagement with thought leaders, and build cutting-edge data generation programs. Success in these areas allows the medical team to provide leadership and demonstrate maximum value to your brand and organization. Learn more at https://lumanity.com/solutions/strategy-consulting/medical-affairs/